Continuing evolution of migraine-specific therapies — targeting migraine with precision and persistence

IF 28.2 1区医学 Q1 CLINICAL NEUROLOGY Nature Reviews Neurology Pub Date : 2024-10-07 DOI:10.1038/s41582-024-01026-x

Dimos D. Mitsikostas, Alan Rapoport

引用次数: 0

Abstract

Treatment options for migraine have expanded rapidly over the past few years. The latest success in a phase II trial of a new class of drugs for migraine holds the promise of another alternative, with important implications for our understanding of migraine and its clinical management.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

偏头痛特效疗法的不断发展--精准、持久地治疗偏头痛

在过去几年中，偏头痛的治疗方案迅速增多。最近，一类治疗偏头痛的新药在二期试验中获得成功，有望成为另一种选择，这对我们了解偏头痛及其临床治疗具有重要意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Nature Reviews Neurology 医学-临床神经学

CiteScore

29.90

自引率

0.80%

发文量

138

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Neurology aims to be the premier source of reviews and commentaries for the scientific and clinical communities we serve. We want to provide an unparalleled service to authors, referees, and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians working in the field of neurology. Our broad scope ensures that the work we publish reaches the widest possible audience. Our articles are authoritative, accessible, and enhanced with clearly understandable figures, tables, and other display items. This page gives more detail about the aims and scope of the journal.

期刊最新文献

Intracerebral haemorrhage - mechanisms, diagnosis and prospects for treatment and prevention. Glymphatic dysfunction in PD clinical progression Dementia risk scores in diverse populations High prevalence of hepatitis B in NMOSD Immune responses influence sex differences in Alzheimer disease